Letters to the Editor

IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy

Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Department of Malignant Hematology, H Lee Moffitt Cancer Center, Tampa, Fl
Haematologica Early view Nov 24, 2022 https://doi.org/10.3324/haematol.2022.281607